Journal article
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study
Abstract
BACKGROUND: There are few data on the relative efficacy and safety of direct oral anticoagulants, such as edoxaban, compared with vitamin K antagonists during extended therapy for venous thromboembolism. This analysis evaluates the risk-benefit of extended treatment for up to 12 months with edoxaban compared with warfarin among patients enrolled in the Hokusai-VTE study who continued therapy beyond 3 months.
METHODS: The Hokusai-VTE trial …
Authors
Raskob G; Ageno W; Cohen AT; Brekelmans MPA; Grosso MA; Segers A; Meyer G; Verhamme P; Wells PS; Lin M
Journal
The Lancet Haematology, Vol. 3, No. 5, pp. e228–e236
Publisher
Elsevier
Publication Date
May 2016
DOI
10.1016/s2352-3026(16)00023-5
ISSN
2352-3026